Coursera Plus Annual is 40% Off — Ends July 13.

Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

YouTube

Evolutionary Immunotherapy in NSCLC - Optimal Dosing in Adoptive Cell Therapy

Mathematical Oncology via YouTube

Start learning Write review
Boot.dev Ad

The Fastest Way to Become a Backend Developer Online

Learn More → Coursera Ad

Learn AI, Data Science & Business — Earn Certificates That Get You Hired

Learn More →

Overview

Google, IBM & Meta Certificates – 40% Off
One plan covers every Professional Certificate on Coursera.
Unlock All Certificates
Explore optimal dosing strategies for adoptive cell therapies in non-small cell lung cancer (NSCLC) through this 14-minute conference talk that applies agent-based modeling to evolutionary immunotherapy approaches. Learn how mathematical oncology principles can be used to identify the most effective dosing protocols for adoptive cell therapies, examining the evolutionary dynamics between cancer cells and therapeutic immune cells. Discover how computational modeling techniques can inform clinical decision-making in immunotherapy treatment planning, with specific focus on optimizing therapeutic outcomes while minimizing potential resistance development in NSCLC patients.

Syllabus

Sandhya Prabhakaran: "Evolutionary immunotherapy in NSCLC: Optimal dosing in adoptive cell therapy"

Taught by

Mathematical Oncology

Reviews

Start your review of Evolutionary Immunotherapy in NSCLC - Optimal Dosing in Adoptive Cell Therapy

Start learning

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free
Someone learning on their laptop while sitting on the floor.